Opportunity ID: 305017

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-18-781
Funding Opportunity Title: Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 11, 2018
Last Updated Date:
Original Closing Date for Applications: Sep 09, 2020
Current Closing Date for Applications: Sep 09, 2020
Archive Date: Oct 15, 2020
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
Independent school districts
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
City or township governments
State governments
County governments
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune responses. Research areas supported by this FOA include: immune system development, function or regulation; mechanisms governing immune response to infectious pathogens, vaccines or adjuvants; host susceptibility factors and mechanisms of pathogen-induced immunopathology; and immune mechanisms involved in the development and progression of immune-mediated diseases, such as allergy/asthma, autoimmunity, primary immunodeficiency, inflammation, and cell/organ/tissue transplant rejection or tolerance.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-18-781.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00242003 Aug 04, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259962 Aug 04, 2018 Sep 09, 2020 View

Package 1

Mandatory forms

305017 RR_SF424_2_0-2.0.pdf

305017 PHS398_CoverPageSupplement_4_0-4.0.pdf

305017 RR_OtherProjectInfo_1_4-1.4.pdf

305017 PerformanceSite_2_0-2.0.pdf

305017 RR_KeyPersonExpanded_2_0-2.0.pdf

305017 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

305017 RR_Budget_1_4-1.4.pdf

305017 RR_SubawardBudget30_1_4-1.4.pdf

305017 PHS398_ModularBudget_1_2-1.2.pdf

305017 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

305017 RR_SF424_2_0-2.0.pdf

305017 PHS398_CoverPageSupplement_5_0-5.0.pdf

305017 RR_OtherProjectInfo_1_4-1.4.pdf

305017 PerformanceSite_2_0-2.0.pdf

305017 RR_KeyPersonExpanded_2_0-2.0.pdf

305017 PHS398_ResearchPlan_4_0-4.0.pdf

305017 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

305017 RR_Budget_1_4-1.4.pdf

305017 RR_SubawardBudget30_1_4-1.4.pdf

305017 PHS398_ModularBudget_1_2-1.2.pdf

305017 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T13:41:11-05:00

Share This Post, Choose Your Platform!

About the Author: